Medical Diagnostics

Japan Approves Subcutaneous Leqembi Pen for Early Alzheimer’s Disease

Leqembi Pen may reduce the time required for treatment administration compared with IV infusions...

Mayo Clinic and Thermo Fisher Scientific Launch Precure to Advance Population-Scale Precision Medicine

Initiative will combine one million biospecimens with longitudinal clinical data and advanced proteomics technologies to uncover early biological signals of disease...

Longevity medicine must prove meaningful health outcomes, not just younger biological age: Andrea B. Maier

Professor Andrea B. Maier, Co-Founder of Chi Longevity, discusses evidence-based longevity medicine, biomarker selection, multidisciplinary care and what it will take to make precision geromedicine scalable across Asia....

Helix Launches Whole Exome+ Sequencing for Patients with Rare and Unexplained Genetic Conditions

For patients with unexplained developmental delay, neurological conditions, and rare genetic disease, WES+ brings exome, mitochondrial, and chromosomal analysis together in a single order...

Tucker Medical installs GE HealthCare MRI system to strengthen personalised preventive care in Singapore

The Singapore clinic has installed a SIGNA 1.5T MRI platform and entered an MoU with GE HealthCare covering clinical education, knowledge exchange and imaging development across Southeast Asia....

Smartee launches paediatric craniofacial growth guidance system in Malaysia

AG KIDS combines craniofacial growth assessment with screening for sleep-related breathing concerns and referral pathways involving dental, ENT and sleep specialists....

SGH leads regional push to expand intestinal ultrasound for IBD monitoring

The initiative with IBUS and Johnson & Johnson will train 19 gastroenterologists and aims to establish 15 IUS-capable centres across Southeast Asia and India....

Manulife, Breast Cancer Foundation and Parkway Radiology expand access to breast cancer screening

The three-year Singapore partnership will provide free tele-consultations and clinically appropriate mammograms through the MammoXpress mobile screening service, including for younger women and underserved groups....

SimonMed and Optellum integrate AI lung nodule risk assessment into imaging workflow

The partnership combines lung nodule detection, characterisation and malignancy-risk prediction within a single radiology workflow using multiple FDA-cleared AI technologies....

Pillar Biosciences joins LC-SCRUM-Asia lung cancer liquid biopsy screening programme

Pillar’s oncoReveal Essential+ assay has been validated at LSI Medience for cfDNA and cfRNA screening, with the project expected to include about 2,000 lung cancer patients over two years....